catalystorthop

"Despite an up-and-down year, Catalyst Orthoscience appears poised for takeoff in the new year. One big aid? It has a product surgeons and patients alike love." View Article, Dec 20, 2021

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.

Published peer reviewed study show significant improvements in motion and patient-reported measures in adult shoulder replacement patients of all ages.

In this article, Alejandro Badia, MD, founder and chief medical officer of the Florida-based Badia Hand to Shoulder Center and OrthoNOW®, discusses partial joint replacement and mentions the Catalyst CSR Total Shoulder System's "stemless, non-spherical implant and patented instrumentation that can be used for partial or total joint replacements for…